Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA NATCO PHARMA AJANTA PHARMA/
NATCO PHARMA
 
P/E (TTM) x 38.3 13.3 287.2% View Chart
P/BV x 8.3 3.5 237.9% View Chart
Dividend Yield % 0.3 0.6 54.1%  

Financials

 AJANTA PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
NATCO PHARMA
Mar-23
AJANTA PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,426847 168.4%   
Low Rs1,062502 211.6%   
Sales per share (Unadj.) Rs297.2148.4 200.4%  
Earnings per share (Unadj.) Rs46.739.2 119.1%  
Cash flow per share (Unadj.) Rs57.148.2 118.5%  
Dividends per share (Unadj.) Rs7.005.50 127.3%  
Avg Dividend yield %0.60.8 69.0%  
Book value per share (Unadj.) Rs269.1267.1 100.7%  
Shares outstanding (eoy) m125.91182.47 69.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.24.5 92.1%   
Avg P/E ratio x26.617.2 154.9%  
P/CF ratio (eoy) x21.814.0 155.7%  
Price / Book Value ratio x4.62.5 183.1%  
Dividend payout %15.014.0 106.8%   
Avg Mkt Cap Rs m156,638123,049 127.3%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8514,867 161.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42627,071 138.3%  
Other income Rs m9861,285 76.8%   
Total revenues Rs m38,41328,356 135.5%   
Gross profit Rs m7,8339,117 85.9%  
Depreciation Rs m1,3081,638 79.9%   
Interest Rs m58145 40.3%   
Profit before tax Rs m7,4538,619 86.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5731,466 107.3%   
Profit after tax Rs m5,8807,153 82.2%  
Gross profit margin %20.933.7 62.1%  
Effective tax rate %21.117.0 124.1%   
Net profit margin %15.726.4 59.5%  
BALANCE SHEET DATA
Current assets Rs m28,25230,003 94.2%   
Current liabilities Rs m11,3936,831 166.8%   
Net working cap to sales %45.085.6 52.6%  
Current ratio x2.54.4 56.5%  
Inventory Days Days6663 103.7%  
Debtors Days Days10115 8.9%  
Net fixed assets Rs m18,70726,571 70.4%   
Share capital Rs m253365 69.2%   
"Free" reserves Rs m33,62448,373 69.5%   
Net worth Rs m33,87748,738 69.5%   
Long term debt Rs m130-   
Total assets Rs m47,04756,574 83.2%  
Interest coverage x128.660.4 212.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 166.3%   
Return on assets %12.612.9 97.8%  
Return on equity %17.414.7 118.3%  
Return on capital %22.218.0 123.3%  
Exports to sales %59.90-   
Imports to sales %11.510.2 112.0%   
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,2932,772 154.9%   
Fx inflow Rs m22,42017,256 129.9%   
Fx outflow Rs m4,2932,772 154.9%   
Net fx Rs m18,12714,484 125.2%   
CASH FLOW
From Operations Rs m7,9188,491 93.2%  
From Investments Rs m-5,596-4,771 117.3%  
From Financial Activity Rs m-1,079-3,630 29.7%  
Net Cashflow Rs m1,243208 597.6%  

Share Holding

Indian Promoters % 66.2 49.7 133.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 25.0 103.2%  
FIIs % 9.1 13.7 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 50.3 67.2%  
Shareholders   54,351 207,571 26.2%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Natco Pharma Share Price Performance

Period AJANTA PHARMA Natco Pharma S&P BSE HEALTHCARE
1-Day 2.51% -2.11% 1.18%
1-Month 7.60% -3.19% -0.75%
1-Year 92.91% 72.80% 61.82%
3-Year CAGR 21.63% 4.96% 18.16%
5-Year CAGR 26.85% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.